Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
reports
NeuroBo Pharmaceuticals (NRBO) Stock Price & Analysis
283 Followers
NRBO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.48 - $63.85
Previous Close$0.48
Volume124.29K
Average Volume (3M)398.64K
Market Cap
$13.16M
Enterprise Value-$17.64M
Total Cash (Recent Filing)$30.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)>-0.1
Beta-0.17
Next Earnings
Aug 15, 2023EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.47
Shares Outstanding27,241,685
10 Day Avg. Volume193,748
30 Day Avg. Volume398,636
Standard Deviation0.28
R-Squared0.00051
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)1.41
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NeuroBo Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NRBO FAQ
What was NeuroBo Pharmaceuticals’s price range in the past 12 months?
NeuroBo Pharmaceuticals lowest stock price was $0.47 and its highest was $63.85 in the past 12 months.
What is NeuroBo Pharmaceuticals’s market cap?
Currently, no data Available
When is NeuroBo Pharmaceuticals’s upcoming earnings report date?
NeuroBo Pharmaceuticals’s upcoming earnings report date is Aug 15, 2023 which is in 67 days.
How were NeuroBo Pharmaceuticals’s earnings last quarter?
NeuroBo Pharmaceuticals released its earnings results on May 24, 2023. The company reported -$0.06 earnings per share for the quarter, the consensus estimate of -$0.06 by $0.
Is NeuroBo Pharmaceuticals overvalued?
According to Wall Street analysts NeuroBo Pharmaceuticals’s price is currently Overvalued.
Does NeuroBo Pharmaceuticals pay dividends?
NeuroBo Pharmaceuticals does not currently pay dividends.
What is NeuroBo Pharmaceuticals’s EPS estimate?
NeuroBo Pharmaceuticals’s EPS estimate is -$0.13.
How many shares outstanding does NeuroBo Pharmaceuticals have?
NeuroBo Pharmaceuticals has 27,241,686 shares outstanding.
What happened to NeuroBo Pharmaceuticals’s price movement after its last earnings report?
NeuroBo Pharmaceuticals reported an EPS of -$0.06 in its last earnings report, expectations of -$0.06. Following the earnings report the stock price went down -4.918%.
Which hedge fund is a major shareholder of NeuroBo Pharmaceuticals?
Currently, no hedge funds are holding shares in NRBO
---
NeuroBo Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-96.61%
12-Months-Change
Fundamentals
Return on Equity
-84.45%
Trailing 12-Months
Asset Growth
133.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
---
Top 5 ETFs holding NRBO
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold NRBO. The ETFs are listed according to market value of NRBO within the ETF
---
---